Annual report [Section 13 and 15(d), not S-K Item 405]

Consolidated Statements of Operations and Comprehensive Loss

v3.26.1
Consolidated Statements of Operations and Comprehensive Loss - USD ($)
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Costs and expenses:    
Research and development $ 29,793,146 $ 17,210,548
Selling, general and administrative 23,555,079 11,378,520
Change in fair value contingent consideration $ (1,373,942) $ 0
Revenue From Contract With Customer Product And Service Extensible List us-gaap:GrantMember us-gaap:GrantMember
Total costs and expenses $ 51,974,283 $ 28,589,068
Loss from operations (51,974,283) (28,589,068)
Interest income 3,715,094 1,069,182
Net loss (48,259,189) (27,519,886)
Other comprehensive income (loss), net of tax    
Unrealized gain (loss) on marketable securities 59,050 (38,125)
Comprehensive loss $ (48,200,139) $ (27,558,011)
Net loss per share - basic $ (0.49) $ (1.16)
Net loss per share - diluted $ (0.49) $ (1.16)
Weighted-average number of shares_basic 98,310,190 23,712,220
Weighted-average number of shares_diluted 98,310,190 23,712,220